Guaifenesin 73581-0400
Product NDC
73581-0400- Manufacturer
- Yyba Corp
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 10, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA209215
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(1)
1 TABLET in 1 BOTTLE (73581-400-02)